MigraineMind research summary
Efficacy of pulsed radiofrequency combined with greater occipital nerve blockade in refractory chronic migraine.
J Int Med Res | 2026
Observational studySummary
Chronic migraine can significantly affect a person's quality of life. Many treatments do not work for everyone. Greater occipital nerve blockade is a common treatment for migraines. This study looked at adding pulsed radiofrequency to this treatment. Researchers included 107 patients with chronic migraines who had not improved. These patients were divided into two groups for treatment. One group received nerve blockade alone. The other group received nerve blockade plus pulsed radiofrequency. The study measured pain intensity and how often migraines occurred. Results showed that adding pulsed radiofrequency helped reduce pain and frequency of attacks. This suggests that combining these treatments may be more effective for patients with chronic migraines. Overall, the findings indicate that pulsed radiofrequency could be a beneficial addition to existing migraine treatments for those who struggle to find relief. Clinical relevance: This research indicates that combining pulsed radiofrequency with nerve blockade may improve outcomes for patients with chronic migraines who have not responded to standard treatments.
Key Learning Points
- Chronic migraine can greatly diminish a person's quality of life and may require multiple treatment approaches to find relief.
- Not all migraine treatments work for every patient, highlighting the need for personalized care.
- Greater occipital nerve blockade is a common treatment option for chronic migraines.
- Adding pulsed radiofrequency to nerve blockade has been shown to reduce both pain intensity and frequency of migraine attacks.
- Combining pulsed radiofrequency with nerve blockade could offer better results for patients who have not found relief with standard treatments.
Related migraine research topics
Original research
Read the original publication and review its full methods and findings on PubMed.
MigraineMind is an educational resource designed to complement—not replace—the original scientific literature or clinical judgement. This page is an AI-generated summary of the available paper information and may contain errors. Please consult the original publication.